ABBV - Undervalued Growth And Dividend Growth In Health Technology: Part 11
Introduction
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015. With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector.
On the other hand, there are several examples where operating performance has been exemplary even though stock price performance has been dismal. In my long history analyzing stocks, I have concluded that the combination of strong operating performance coupled with low valuations usually represents great opportunity. The old